Table 1.
Participant characteristics (n = 11)
| Characteristics | Mean ± SD (range) |
|---|---|
| Age (years) | 52 ± 6 (40–60) |
| Body mass (kg) | 91.8 ± 10.4 (65.6-100.9) |
| Height (m) | 1.76 ± 0.07 (1.66–1.89) |
| BMI (kg/m2) | 29.7 ± 3.1 (23.8–34.1) |
| V̇O2max (ml/kg/min) | 28.9 ± 4.8 (18.3–35.3) |
| Systolic blood pressure (mmHg) | 125 ± 12 (114–148) |
| Diastolic blood pressure (mmHg) | 78 ± 7 (70–88) |
| Mean arterial pressure | 93 ± 8 (83–108) |
| Duration of T2D (years) | 4 ± 3 (0.5-8) |
| Fasting glucose (mmol/l) | 8.1 ± 1.2 (7.1–9.7) |
| HbA1c (mmol/mol) | 52 ± 9 (38–67) |
| HbA1c (%) | 7.0 ± 0.8 (5.6–8.3) |
| Medication (n) | |
| Metformin | 7 |
| Metformin + sulfonylurea | 4 |
| Blood pressure lowering | 1 |
| Statin | 5 |
T2D type 2 diabetes